Stempeutics Research
Bridging advanced stem cell science with real-world therapeutic applications.
Advancing Regenerative Science
Stempeutics is a life sciences company focused on developing and commercialising novel therapeutics based on adult stem cell science. Its flagship product - Stempeucel represents India’s first commercially approved cell therapy for knee osteoarthritis and critical limb ischemia, marking a significant advancement in the country’s regenerative‑medicine landscape.
Know more
Joint Venture Partnership
Stempeutics strengthens its mission through strategic collaborations with MEMG, Cipla, and Kemwell Biopharma, combining scientific expertise and industry leadership to advance regenerative medicine and deliver impactful healthcare solutions.